Nathalie Harroy - Inventiva Head of Human Resources
| IVEVF Stock | USD 3.64 0.00 0.00% |
Executive
Ms. Nathalie Harroy serves as Head of Human Resources at Inventiva S.A. She is a Human Resources expert in Research and Development. She has worked for many years with different R D structures. After graduation with DEST in Human Resources, she started her career at Urgo laboratories in the early 1990s before taking HR responsibilities in the RD department of Fournier Pharmaceuticals in 2001. She was instrumental in the Fournier efforts to reorganize its RD organization into a project oriented structure and transform the way the company provides human resources services to the research Unit. She was then responsible for the HR Research activities of Solvay Pharmaceuticals in France until 2007 and then Abbott before joining the Inventiva project as Head of Human Resources. She has acquired an extensive experience in the management of the various HR aspects specific to Research and Development by actively participating in the implementation of several local or globalized structures.
| Age | 56 |
| Phone | 33 3 80 44 75 00 |
| Web | https://www.inventivapharma.com |
Inventiva Management Efficiency
The company has return on total asset (ROA) of (0.3438) % which means that it has lost $0.3438 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7073) %, meaning that it generated substantial loss on money invested by shareholders. Inventiva's management efficiency ratios could be used to measure how well Inventiva manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Hih Kim | Primo Brands | N/A | |
| Syl Saller | Diageo PLC ADR | 60 | |
| Lynn WatkinsAsiyanbi | CECO Environmental Corp | 49 | |
| Brant Burchfield | Celsius Holdings | N/A | |
| Thomas Shropshire | Diageo PLC ADR | N/A | |
| Madhuri Andrews | Jacobs Solutions | 57 | |
| Peter Johansson | CECO Environmental Corp | 60 | |
| Shelette Gustafson | Jacobs Solutions | 59 | |
| Ayan Banerjee | Jacobs Solutions | N/A | |
| Tony Guilfoyle | Celsius Holdings | 52 | |
| Robert Duff | Jacobs Solutions | 65 | |
| Kyle Watson | Celsius Holdings | 42 | |
| Kheri Tillman | Primo Brands | N/A | |
| Danielle Babich | Celsius Holdings | N/A | |
| Paul Storey | Celsius Holdings | 55 | |
| Marni Poe | Primo Brands | 54 | |
| Paul Wiseman | Celsius Holdings | N/A | |
| Jonathan CFA | Jacobs Solutions | N/A | |
| Richard Mattessich | Celsius Holdings | 59 | |
| Robert Austin | Primo Brands | N/A | |
| Nancy Sotomayor | Primo Brands | N/A | |
Management Performance
| Return On Equity | -0.71 | |||
| Return On Asset | -0.34 |
Inventiva SA Leadership Team
Elected by the shareholders, the Inventiva's board of directors comprises two types of representatives: Inventiva inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inventiva. The board's role is to monitor Inventiva's management team and ensure that shareholders' interests are well served. Inventiva's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inventiva's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jean Volatier, Chief Officer | ||
| Eric LLM, G Counsel | ||
| Frederic Cren, CEO, Co-Founder | ||
| JeanPaul MD, Head Pharmacovigilance | ||
| Michael Cooreman, Chief Officer | ||
| Pierre Broqua, Co-Founder, Chief Scientific Officer | ||
| Irena Konstantinova, Head of Fibrosis Research | ||
| Nathalie Harroy, Head of Human Resources |
Inventiva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Inventiva a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.34 | |||
| Operating Margin | (6.37) % | |||
| Current Valuation | 108.8 M | |||
| Shares Outstanding | 42.13 M | |||
| Shares Owned By Insiders | 25.11 % | |||
| Shares Owned By Institutions | 46.96 % | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 21.40 X | |||
| Revenue | 4.19 M |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Inventiva Pink Sheet
When determining whether Inventiva SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inventiva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inventiva Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inventiva Sa Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inventiva SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.